Cargando…
New Strategies for Treatment of Inflammatory Bowel Disease
The etiology of inflammatory bowel disease (IBD), of which ulcerative colitis (UC) and Crohn’s disease (CD) are the two most prevailing entities, is unknown. However, IBD is characterized by an imbalanced synthesis of pro-inflammatory mediators of the inflamed intestine, and for more than a decade t...
Autor principal: | Nielsen, Ole Haagen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4323544/ https://www.ncbi.nlm.nih.gov/pubmed/25685754 http://dx.doi.org/10.3389/fmed.2014.00003 |
Ejemplares similares
-
Rational Management of Iron-Deficiency Anaemia in Inflammatory Bowel Disease
por: Nielsen, Ole Haagen, et al.
Publicado: (2018) -
Management of Iron-Deficiency Anemia in Inflammatory Bowel Disease: A Systematic Review
por: Nielsen, Ole Haagen, et al.
Publicado: (2015) -
Managing vitamin D deficiency in inflammatory bowel disease
por: Nielsen, Ole Haagen, et al.
Publicado: (2019) -
Efficacy and safety of methotrexate in the management of inflammatory bowel disease: A systematic review and meta-analysis of randomized, controlled trials
por: Nielsen, Ole Haagen, et al.
Publicado: (2020) -
Investigating dysbiosis and microbial treatment strategies in inflammatory bowel disease based on two modified Koch’s postulates
por: Zhao, HanZheng, et al.
Publicado: (2022)